Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients

Cristina Gervasoni; Sara Baldelli ChemD; Matteo Cerea; Giovanni Cenderello; Teresa Bini; Stefania Vimercati; Rosaria Iardino; Andrea Gazzaniga; Antonella D’Arminio Monforte; Emilio Clementi; Dario Cattaneo

doi:10.1097/FTD.0000000000000273

Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients

Cristina Gervasoni, Sara Baldelli ChemD, Matteo Cerea, Giovanni Cenderello, Teresa Bini, Stefania Vimercati, Rosaria Iardino, Andrea Gazzaniga, Antonella D’Arminio Monforte, Emilio Clementi, Dario Cattaneo

Istituto "Eugenio Medea" - Associazione La Nostra Famiglia

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	420-422
Journal	Therapeutic Drug Monitoring
Volume	38
Issue number	3
DOIs	https://doi.org/10.1097/FTD.0000000000000273
Publication status	Published - Dec 30 2016

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology

Access to Document

10.1097/FTD.0000000000000273

Cite this

Gervasoni, C., ChemD, S. B., Cerea, M., Cenderello, G., Bini, T., Vimercati, S., Iardino, R., Gazzaniga, A., D’Arminio Monforte, A., Clementi, E., & Cattaneo, D. (2016). Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients. Therapeutic Drug Monitoring, 38(3), 420-422. https://doi.org/10.1097/FTD.0000000000000273

Gervasoni, C, ChemD, SB, Cerea, M, Cenderello, G, Bini, T, Vimercati, S, Iardino, R, Gazzaniga, A, D’Arminio Monforte, A, Clementi, E & Cattaneo, D 2016, 'Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients', Therapeutic Drug Monitoring, vol. 38, no. 3, pp. 420-422. https://doi.org/10.1097/FTD.0000000000000273

@article{e8815c90a71948fca582c170e8ea76e3,

title = "Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients",

author = "Cristina Gervasoni and ChemD, {Sara Baldelli} and Matteo Cerea and Giovanni Cenderello and Teresa Bini and Stefania Vimercati and Rosaria Iardino and Andrea Gazzaniga and {D{\textquoteright}Arminio Monforte}, Antonella and Emilio Clementi and Dario Cattaneo",

year = "2016",

month = dec,

day = "30",

doi = "10.1097/FTD.0000000000000273",

language = "English",

volume = "38",

pages = "420--422",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients

AU - Gervasoni, Cristina

AU - ChemD, Sara Baldelli

AU - Cerea, Matteo

AU - Cenderello, Giovanni

AU - Bini, Teresa

AU - Vimercati, Stefania

AU - Iardino, Rosaria

AU - Gazzaniga, Andrea

AU - D’Arminio Monforte, Antonella

AU - Clementi, Emilio

AU - Cattaneo, Dario

PY - 2016/12/30

Y1 - 2016/12/30

UR - http://www.scopus.com/inward/record.url?scp=84953324797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953324797&partnerID=8YFLogxK

U2 - 10.1097/FTD.0000000000000273

DO - 10.1097/FTD.0000000000000273

M3 - Article

AN - SCOPUS:84953324797

SN - 0163-4356

VL - 38

SP - 420

EP - 422

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 3

ER -

Comparison of the in vivo pharmacokinetics and in vitro dissolution of branded versus generic efavirenz formulation in HIV-infected patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this